Xiaojuan Chao

Xiaojuan Chao

Auto-generated profile, based on publicly available information

Xiaojuan Chao

Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2021 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
HQHui Qian
Hui Qian
XCXiaojuan Chao
Xiaojuan Chao
JWJessica Williams
Jessica Williams
SFSam Fulte
Sam Fulte
TLTiangang Li
Tiangang Li
Wen-Xing DingWen-Xing Ding
Wen-Xing Ding

1 September 2018 in Gastroenterology
Verified
Journal Article
Closed access
XCXiaojuan Chao
Xiaojuan Chao
SWShaogui Wang
Shaogui Wang
KZKatrina Zhao
Katrina Zhao
YLYuan Li
Yuan Li
JWJessica A. Williams
Jessica A. Williams
Wen-Xing DingWen-Xing Ding
Wen-Xing Ding

19 April 2022 in Journal of Hepatology
Verified
Journal Article
Open access
XJXiaoxiao Jiang
Xiaoxiao Jiang
SFSam Fulte
Sam Fulte
FDFengyan Deng
Fengyan Deng
SCShiyuan Chen
Shiyuan Chen
YXYan Xie
Yan Xie
HNHongmin Ni
Hongmin Ni
Vacuole membrane protein 1 (VMP1) is an endoplasmic reticulum (ER) transmembrane protein that regulates the formation of autophagosomes and lipid droplets. Recent evidence suggests that VMP1 plays a critical role in lipoprotein secretion in zebra fish and cultured cells. However, the pathophysiological roles and mechanisms by which VMP1 regulates lipoprotein secretion and lipid accumulation in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are unknown. Liver-specific and hepatocyte-specific Vmp1 knockout mice as well as Vmp1 knock-in mice were generated by crossing Vmp1flox or Vmp1KI mice with albumin-Cre mice or by injecting AAV8-TBG-cre, respectively. Lipid and energy metabolism in these mice were characterized by metabolomic and transcriptome analyses. Mice with hepatic overexpression of VMP1 who were fed a NASH diet were also characterized. Hepatocyte-specific deletion of Vmp1 severely impaired VLDL secretion resulting in massive hepatic steatosis, hepatocyte death, inflammation and fibrosis, which are hallmarks of NASH. Mechanistically, loss of Vmp1 led to decreased hepatic levels of phosphatidylcholine and phosphatidylethanolamine as well as to changes in phospholipid composition. Deletion of Vmp1 in mouse liver also led to the accumulation of neutral lipids in the ER bilayer and impaired mitochondrial beta-oxidation. Overexpression of VMP1 ameliorated steatosis in diet-induced NASH by improving VLDL secretion. Importantly, we also showed that decreased liver VMP1 is associated with NAFLD/NASH in humans. Our results provide novel insights on the role of VMP1 in regulating hepatic phospholipid synthesis and lipoprotein secretion in the pathogenesis of NAFLD/NASH. Non-alcoholic fatty liver disease and its more severe form, non-alcoholic steatohepatitis, are associated with a build-up of fat in the liver (steatosis). However, the exact mechanisms that underly steatosis in patients are not completely understood. Herein, the authors identified that the lack of a protein called VMP1 impairs the secretion and metabolism of fats in the liver and could therefore contribute to the development and progression of non-alcoholic fatty liver disease.

25 October 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
XCXiaojuan Chao
Xiaojuan Chao
SWShaogui Wang
Shaogui Wang
SFSam Fulte
Sam Fulte
XMXiaowen Ma
Xiaowen Ma
FAForkan Ahamed
Forkan Ahamed
Wen-Xing DingWen-Xing Ding
Wen-Xing Ding

1 July 2019 in The American Journal of Pathology
Verified
Journal Article
Closed access
HNHongmin Ni
Hongmin Ni
XCXiaojuan Chao
Xiaojuan Chao
JKJoshua Kaseff
Joshua Kaseff
FDFengyan Deng
Fengyan Deng
SWShaogui Wang
Shaogui Wang
Hartmut JaeschkeHartmut Jaeschke
Hartmut Jaeschke

29 October 2023 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
XCXiaojuan Chao
Xiaojuan Chao
MNMengwei Niu
Mengwei Niu
SWShaogui Wang
Shaogui Wang
XMXiaowen Ma
Xiaowen Ma
XYXiao Yang
Xiao Yang
Wen-Xing DingWen-Xing Ding
Wen-Xing Ding
Macroautophagy (referred to as autophagy hereafter) is a major intracellular lysosomal degradation pathway that is responsible for the degradation of misfolded/damaged proteins and organelles. Previous studies showed that autophagy protects against acetaminophen (APAP)-induced injury (AILI) via selective removal of damaged mitochondria and APAP protein adducts. The lysosome is a critical organelle sitting at the end stage of autophagy for autophagic degradation via fusion with autophagosomes. In the present study, we showed that transcription factor EB (TFEB), a master transcription factor for lysosomal biogenesis, was impaired by APAP resulting in decreased lysosomal biogenesis in mouse livers. Genetic loss-of and gain-of function of hepatic TFEB exacerbated or protected against AILI, respectively. Mechanistically, overexpression of TFEB increased clearance of APAP protein adducts and mitochondria biogenesis as well as SQSTM1/p62-dependent non-canonical nuclear factor erythroid 2-related factor 2 (NRF2) activation to protect against AILI. We also performed an unbiased cell-based imaging high-throughput chemical screening on TFEB and identified a group of TFEB agonists. Among these agonists, salinomycin, an anticoccidial and antibacterial agent, activated TFEB and protected against AILI in mice. In conclusion, genetic and pharmacological activating TFEB may be a promising approach for protecting against AILI.